查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
3D印刷医药品的全球市场 - 产业规模，占有率，趋势，机会，预测:各技术，各用途，各终端用户，各地区(2017年～2027年)
市场调查报告书
商品编码
1171626

3D印刷医药品的全球市场 - 产业规模，占有率，趋势，机会，预测:各技术，各用途，各终端用户，各地区(2017年～2027年)

3D Printed Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Technology, By Application, By End User, By Region
出版日期: | 出版商: TechSci Research | 英文 119 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球3D印刷医药品的市场规模，预计在预测期间内达成惊人的成长。

，人们和患者之间意识高涨，成为市场成长的要素。

关于3D印刷医药品的使用相关优点还有患吞嚥障碍证的患者增加，也支撑今后数年的市场成长。再加上政府组织对各种病相关的开发新药的投资增加，人们和医护人员之间对3D印刷医药品的使用相关意识高涨，预计更加推动在预测期间内的市场成长，个人化医疗的人气高涨，产生对市场成长有利的机会。

本报告提供全球3D印刷医药品市场相关调查分析，各市场区隔、各地区的市场规模、占有率预测，市场动态，企业简介等系统性资讯。

目录

第1章 产品概要

第2章 调查手法

第3章 摘要整理

第4章 COVID-19对全球3D印刷医药品市场的影响

第5章 VOC (客户的迴响)

第6章 全球3D印刷医药品市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各技术(喷墨印刷，熔融沉积建模，立体光固成型，ZipDose技术，其他)
    • 各用途(整形外科，神经科，牙科，其他)
    • 各终端用户(医院、诊所，学术、研究机关，其他)
    • 各企业(2021年)
    • 各地区
  • 市场地图

第7章 北美的3D印刷医药品市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各技术
    • 各用途
    • 各终端用户
    • 各国
  • 各国分析
    • 美国
    • 加拿大
    • 墨西哥

第8章 欧洲的3D印刷医药品市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各技术
    • 各用途
    • 各终端用户
    • 各国
  • 各国分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第9章 亚太地区的3D印刷医药品市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各技术
    • 各用途
    • 各终端用户
    • 各国
  • 各国分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第10章 南美的3D印刷医药品市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各技术
    • 各用途
    • 各终端用户
    • 各国
  • 各国分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第11章 中东、非洲的3D印刷医药品市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各技术
    • 各用途
    • 各终端用户
    • 各国
  • 各国分析
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 土耳其
    • 埃及

第12章 市场动态

  • 促进因素
  • 课题

第13章 市场趋势与开发

第14章 竞争情形

  • Aprecia Pharmaceuticals, LLC.
  • FabRx Ltd.
  • Merck & Co. Inc.
  • Triastek, Inc.
  • GlaxoSmithKline plc.
  • Formac Pharmaceuticals N.V.
  • AstraZeneca plc
  • Extend Biosciences, Inc.
  • Affinity Therapeutics, LLC
  • Osmotica Pharmaceuticals Corporation

第15章 策略性建议

简介目录
Product Code: 12970

The global 3d printed drugs market is anticipated to witness an impressive growth during the forecast period. This can be ascribed to increasing awareness amongst people and patients regarding the benefits associated with the usage of 3D printed drugs. Besides increasing number of patients suffering from dysphagia is expected to support the market growth in the coming years. Dysphagia is characterized by difficulty in swallowing. In this disease, it takes more time and effort to move food or liquid from mouth to stomach. 3D printed drugs are drugs created by 3D printing technology that are used to treat patients suffering from dysphagia. 3D printed drugs have a porous structure that can rapidly disintegrate in the mouth. Besides, increasing investments by government organizations for inventing new drugs related to different diseases couples with growing awareness regarding usage of 3D printed drugs among people and healthcare providers will further boost the market growth in the forecast period. Furthermore, growing popularity of personalized medicine is further expected to create lucrative opportunities for the market growth.

Increasing Prevalence of Chronic Diseases

The growing prevalence of chronic diseases such as diabetes, cancer, cardiovascular diseases, renal problems, among others across the globe is expected to create lucrative opportunities for the growth of global 3D printed drugs market. According to global cancer observatory, around 19,292,789 new cancer cases were reported worldwide in 2020, with breast cancer, lung cancer, colorectum cancer, prostate cancer and stomach cancer being the most prevalent types. This in turn is expected to increase the demand for 3D printed drugs for the treatment of different types of cancers. Additionally, growing geriatric population across the globe which is susceptible to various diseases requires medications that are not only effective but also affordable, thereby fuelling the growth of global 3D printed drugs market.

Benefits Associated With 3D Printed Drugs

There are numerous benefits associated with the use of 3D Printed Drugs such as using this technique medicines can be produced in small batches with carefully tailored shapes, dosages, and sizes, among others. In addition, the use of 3D printing technology can significantly reduce manufacturing costs. This in turn is expected to increase investments in this space, thereby supporting the market growth during the forecast period. However, increased awareness of the benefits of these medications, such as their immediate solubility, faster manufacturing time, reduced waste, and easy on-demand manufacturing is likely to create multiple prospects for market growth.

Market Segmentation

The Global 3D Printed Drugs market can be segmented by technology, by application, by end user, and by region. Based on technology, the market can be categorized into inkjet printing, fused deposition modeling, stereolithography, zipdose technology, and others. Based on application, the market can be fragmented into orthopedic, neurology, dental, and others. Based on end user, the market can be grouped into hospitals & clincs, academic & research institutions, and others. Regionally, North America dominated the market among Europe, Asia Pacific, Middle East & Africa, and South America. Among the different countries, United States dominated the Global 3D Printed Drugs Market on account of growing adoption, use and availability of personalized medicines in the United States. The number of personalized medicines available in the United States in 2020 were around 286.

Market Players

Aprecia Pharmaceuticals, LLC., FabRx Ltd., Merck & Co. Inc., Triastek, Inc., GlaxoSmithKline plc., Formac Pharmaceuticals N.V., AstraZeneca plc, Extend Biosciences, Inc., Affinity Therapeutics, LLC, Osmotica Pharmaceuticals Corporation are some of the leading players operating in the Global 3D Printed Drugs Market.

Report Scope

In this report, Global 3D Printed Drugs Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

3D Printed Drugs Market, By Technology:

  • Inkjet Printing
  • Fused Deposition Modeling
  • Stereolithography
  • Zip Dose Technology
  • Others

3D Printed Drugs Market, By Application:

  • Orthopedic
  • Neurology
  • Dental
  • Others

3D Printed Drugs Market, By End User:

  • Hospital & Clinics
  • Academic & Research Institutions
  • Others

3D Printed Drugs Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global 3D Printed Drugs Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global 3D Printed Drugs Market

5. Voice of Customer

6. Global 3D Printed Drugs Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology (Inkjet Printing, Fused Deposition Modeling, Stereolithography, ZipDose Technology, Others)
    • 6.2.2. By Application (Orthopedic, Neurology, Dental, Others)
    • 6.2.3. By End User (Hospitals & Clincs, Academic & Research Institutions, Others)
    • 6.2.4. By Company (2021)
    • 6.2.5. By Region
  • 6.3. Market Map

7. North America 3D Printed Drugs Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States 3D Printed Drugs Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Canada 3D Printed Drugs Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Mexico 3D Printed Drugs Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User

8. Europe 3D Printed Drugs Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France 3D Printed Drugs Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany 3D Printed Drugs Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom 3D Printed Drugs Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy 3D Printed Drugs Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain 3D Printed Drugs Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Asia-Pacific 3D Printed Drugs Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China 3D Printed Drugs Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. India 3D Printed Drugs Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Japan 3D Printed Drugs Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User
    • 9.3.4. South Korea 3D Printed Drugs Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Technology
        • 9.3.4.2.2. By Application
        • 9.3.4.2.3. By End User
    • 9.3.5. Australia 3D Printed Drugs Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Technology
        • 9.3.5.2.2. By Application
        • 9.3.5.2.3. By End User

10. South America 3D Printed Drugs Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil 3D Printed Drugs Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina 3D Printed Drugs Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia 3D Printed Drugs Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Middle East and Africa 3D Printed Drugs Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Technology
    • 11.2.2. By Application
    • 11.2.3. By End User
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa 3D Printed Drugs Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Technology
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia 3D Printed Drugs Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Technology
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE 3D Printed Drugs Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Technology
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By End User
    • 11.3.4. Turkey 3D Printed Drugs Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Technology
        • 11.3.4.2.2. By Application
        • 11.3.4.2.3. By End User
    • 11.3.5. Egypt 3D Printed Drugs Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Technology
        • 11.3.5.2.2. By Application
        • 11.3.5.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Aprecia Pharmaceuticals, LLC.
  • 14.2. FabRx Ltd.
  • 14.3. Merck & Co. Inc.
  • 14.4. Triastek, Inc.
  • 14.5. GlaxoSmithKline plc.
  • 14.6. Formac Pharmaceuticals N.V.
  • 14.7. AstraZeneca plc
  • 14.8. Extend Biosciences, Inc.
  • 14.9. Affinity Therapeutics, LLC
  • 14.10. Osmotica Pharmaceuticals Corporation

15. Strategic Recommendations